Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Dive in: gaining leadership in a therapeutic area

Dive in: gaining leadership in a therapeutic area neu (4B5) Rabbit Monoclonal Primary Antibody assay marketed by its subsidiary Ventana - used to detect breast cancer patients eligible for Herceptin, Perjeta and Kadcyla.

Back to the future

Back to the future In 2013, Roche's biologics sales totalled $29.2bn. These were led by established oncology brands such as Avastin and MabThera/Rituxan, along with emerging breast cancer therapies such as Perjeta

NICE rejects Roche's Kadcyla as "unaffordable"

NICE rejects Roche's Kadcyla as The company is facing the threat of biosimilar competition to Herceptin later this year and had its Perjeta (pertuzumab) breast cancer drug rejected by NICE in draft guidance published in 2013.

Pharma's winners and losers in 2013

Pharma's winners and losers in 2013 well as emerging therapies such as breast cancer therapies Perjeta (pertuzumab) and Kadcyla (trastuzumab emtansine).

Roche signs biologics partnership with Samsung

Roche signs biologics partnership with Samsung Roche's biologics portfolio includes the cancer drugs Kadcyla (trastuzumab emtansine) and Perjeta (pertuzumab), which launched this year and brought in 191m Swiss francs (about $214m) in the first half of

[ Previous 5 results ] 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...